Avenue Therapeutics Inc. buy krebskrebs
Start price
18.10.21
/
50%
€16.50
Target price
18.10.22
€30.00
Performance (%)
-76.27%
End price
19.10.22
€3.92
Summary
This prediction ended on 19.10.22 with a price of €3.92. The BUY prediction by krebskrebs for Avenue Therapeutics Inc. performed very badly with a performance of -76.27%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avenue Therapeutics Inc. | -12.419% | -12.419% | -87.239% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
Comments by krebskrebs for this prediction
In the thread Avenue Therapeutics diskutieren
In the thread Trading Avenue Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten